Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Century Therapeutics (IPSC) Leases (2022 - 2025)

Century Therapeutics (IPSC) has disclosed Leases for 4 consecutive years, with $16.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Leases fell 42.54% to $16.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $16.6 million, a 42.54% decrease, with the full-year FY2024 number at $28.7 million, up 40.88% from a year prior.
  • Leases was $16.6 million for Q3 2025 at Century Therapeutics, down from $27.7 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $29.5 million in Q3 2022 to a low of $11.7 million in Q1 2022.
  • A 4-year average of $24.7 million and a median of $27.7 million in 2025 define the central range for Leases.
  • Peak YoY movement for Leases: skyrocketed 141.71% in 2023, then tumbled 42.54% in 2025.
  • Century Therapeutics' Leases stood at $28.9 million in 2022, then decreased by 29.6% to $20.4 million in 2023, then skyrocketed by 40.88% to $28.7 million in 2024, then tumbled by 42.29% to $16.6 million in 2025.
  • Per Business Quant, the three most recent readings for IPSC's Leases are $16.6 million (Q3 2025), $27.7 million (Q2 2025), and $28.2 million (Q1 2025).